[Why and how evaluating driving abilities in patients with neurodegenerative diseases?]

Chloé Lazeras1, Mégane Cartier1, Marie Bonnet2

  • 1Centre mémoire de ressources et de recherches, Pôle de neurosciences cliniques, CHU de Bordeaux, France.